Dos Santos, Alexandre Moura, Misse, Rafael Giovani, Borges, Isabela Bruna Pires et al. · Rheumatology advances in practice · 2022 · DOI
This study compared 53 patients with Takayasu arteritis (a rare blood vessel disease) to 100 healthy people and found that fatigue is much more common in patients with this condition. Patients with Takayasu arteritis also had more difficulty doing daily activities and were less physically active than healthy people. The researchers suggest that doctors should specifically treat fatigue as part of caring for these patients.
While this study focuses on Takayasu arteritis rather than ME/CFS, it demonstrates important methodological approaches for measuring fatigue severity and functional impact in chronic inflammatory conditions, which is directly applicable to ME/CFS research. Understanding how fatigue affects multiple domains of functioning and correlates with inflammatory markers and disease activity in other conditions can inform similar investigations in ME/CFS populations.
This study does not establish that the fatigue in Takayasu arteritis has the same underlying mechanisms as ME/CFS fatigue, nor does it prove causality between inflammatory markers and fatigue severity—only correlation. Additionally, findings in a rare vasculitic disease cannot be directly generalized to ME/CFS without independent validation in ME/CFS populations.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →